HER2 Transmembrane Domain Dimerization Coupled with Self-Association of Membrane-Embedded Cytoplasmic Juxtamembrane Regions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HER2 Transmembrane Domain Dimerization Coupled with Self-Association of Membrane-Embedded Cytoplasmic Juxtamembrane Regions

Published:2016-01 Issue:1 Volume:428 Page:52-61
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Bragin Pavel E.,Mineev Konstantin S.,Bocharova Olga V.,Volynsky Pavel E.,Bocharov Eduard V.,Arseniev Alexander S.

Funder

Russian Science Foundation

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference52 articles.

1. Cell signaling by receptor tyrosine kinases;Lemmon;Cell,2010

2. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells;Tao;J. Cell Sci.,2008

3. A dimerization hierarchy in the transmembrane domains of the HER receptor family;Duneau;Biochemistry,2007

4. Transmembrane peptides as inhibitors of ErbB receptor signaling;Bennasroune;Mol. Biol. Cell,2004

5. Ligand-induced ErbB receptor dimerization;Lemmon;Exp. Cell Res.,2009

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes;Cancer Treatment Reviews;2024-11

2. Human Blood Serum Antagonizes Effects of EGFR/HER2-Targeted Drug Lapatinib on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression;Биохимия;2024-09-14

3. Substrate Selection Criteria in Regulated Intramembrane Proteolysis;ACS Chemical Neuroscience;2024-03-25

4. Human Blood Serum Counteracts EGFR/HER2-Targeted Drug Lapatinib Impact on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression;Biochemistry (Moscow);2024-03

5. A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells;Frontiers in Immunology;2023-10-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3